|
|
 |
|
|
Pressemitteilung - 15.04.2010
Kenta Biotech reports 100% survival with panobacumab in life-threatening hospital-acquired pneumonia | 
eng |
ger |  | Pressemitteilung - 14.01.2010
Kenta Biotech Announces Collaboration with Rentschler Biotechnologie for Antibody Development |
eng |
ger | | Pressemitteilung - 14.09.2009
Kenta Biotech reports Phase IIa data with lead candidate panobacumab in hospital-acquired pneumonia. |
eng | | EMEA - Public summary of positive opinion for orphan designation - 14.05.2009
|
eng | | Pressemitteilung - 12.03.2009
Kenta Biotech raises CHF 12 Million in Series B Private Financing. |
eng | | Kenta Presentation at BioEurope Spring Conference, Milano - 12.03.2009
|
eng | | Partnering News - BioEurope Spring Conference - 06.03.2009
|
eng | | Pharma Wire - 14.12.2008
|
eng | | SwissBiotech Report - 13.11.2008
|
eng | | CASH - 07.12.2006
|
ger | | Pressemitteilung - 03.10.2006
Kenta Biotech Obtains FDA Orphan Drug Designation for Human Monoclonal Antibody against Pseudomonas Pneumonia... |
eng |
ger | | Pressemitteilung - 19.07.2006
Kenta Biotech Obtains Orphan Drug Status for Human Monoclonal Antibody against Pseudomonas Pneumonia... |
eng |
ger | | Swiss Equity - 22.06.2006
|
ger | | Pressemitteilung - 08.05.2006
Kenta Biotech Ltd founded with the aim to discover and develop fully human monoclonal antibodies... |
eng |
ger |
|
|
|
